Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna Ferrari; Joshi J. Alumkal; Mark Stein; Mary Ellen Taplin; James Babb; Ethan S. Barnett; Alejandro Gomez-Pinillos; Xiaomei Liu; Dirk Moore; Robert DiPaola; Tomasz M. Beer

doi:10.1158/1078-0432.CCR-19-0442

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna Ferrari
, Joshi J. Alumkal
, Mark Stein
, Mary Ellen Taplin
, James Babb
, Ethan S. Barnett
, Alejandro Gomez-Pinillos
, Xiaomei Liu
, Dirk Moore
, Robert DiPaola
, Tomasz M. Beer

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

Original language	English (US)
Pages (from-to)	2672
Number of pages	1
Journal	Clinical Cancer Research
Volume	25
Issue number	8
DOIs	https://doi.org/10.1158/1078-0432.CCR-19-0442
State	Published - Apr 15 2019

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1158/1078-0432.CCR-19-0442

Fingerprint

Dive into the research topics of 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)'. Together they form a unique fingerprint.

Cite this

Ferrari, A., Alumkal, J. J., Stein, M., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R., & Beer, T. M. (2019). Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589). Clinical Cancer Research, 25(8), 2672. https://doi.org/10.1158/1078-0432.CCR-19-0442

@article{b817767b2ff0443fa906f3612e376842,

title = "Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)",

abstract = "In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.",

author = "Anna Ferrari and Alumkal, \{Joshi J.\} and Mark Stein and Taplin, \{Mary Ellen\} and James Babb and Barnett, \{Ethan S.\} and Alejandro Gomez-Pinillos and Xiaomei Liu and Dirk Moore and Robert DiPaola and Beer, \{Tomasz M.\}",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

month = apr,

day = "15",

doi = "10.1158/1078-0432.CCR-19-0442",

language = "English (US)",

volume = "25",

pages = "2672",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

Ferrari, A, Alumkal, JJ, Stein, M, Taplin, ME, Babb, J, Barnett, ES, Gomez-Pinillos, A, Liu, X, Moore, D, DiPaola, R & Beer, TM 2019, 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)', Clinical Cancer Research, vol. 25, no. 8, pp. 2672. https://doi.org/10.1158/1078-0432.CCR-19-0442

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589). / Ferrari, Anna; Alumkal, Joshi J.; Stein, Mark et al.
In: Clinical Cancer Research, Vol. 25, No. 8, 15.04.2019, p. 2672.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction

T2 - Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

AU - Ferrari, Anna

AU - Alumkal, Joshi J.

AU - Stein, Mark

AU - Taplin, Mary Ellen

AU - Babb, James

AU - Barnett, Ethan S.

AU - Gomez-Pinillos, Alejandro

AU - Liu, Xiaomei

AU - Moore, Dirk

AU - DiPaola, Robert

AU - Beer, Tomasz M.

PY - 2019/4/15

Y1 - 2019/4/15

N2 - In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

AB - In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

UR - https://www.scopus.com/pages/publications/85064926889

UR - https://www.scopus.com/pages/publications/85064926889#tab=citedBy

U2 - 10.1158/1078-0432.CCR-19-0442

DO - 10.1158/1078-0432.CCR-19-0442

M3 - Comment/debate

C2 - 30988096

AN - SCOPUS:85064926889

SN - 1078-0432

VL - 25

SP - 2672

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 8

ER -

Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this